← All organizations

Cogent Biosciences

For profitWebsite ↗

Also known as: Cogent Biosciences | Cogent Biosciences, Inc. | Unum Therapeutics Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jan 22, 2025

Timeline

2010s

Jun 1, 2014
Cogent Biosciences— Founded

Drugs by trial phase (9 distinct, 11 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (5 own, 0 via acquisition)

Indications

Studied for

Recent trials (20)

NCT06948955Lead sponsorN/A—
NCT06915766OfficialN/A—
NCT06948955OfficialN/A—
NCT06915766Lead sponsorN/A—
NCT06777316Lead sponsorPhase 1/Phase 2Jan 22, 2025
NCT06208748CollaboratorPhase 2Jul 31, 2024
NCT05208047Lead sponsorPhase 3Apr 14, 2022
NCT05208047Study directorPhase 3Apr 14, 2022
NCT04996875Lead sponsorPhase 2Nov 9, 2021
NCT04996875Study directorPhase 2Nov 9, 2021
NCT05186753Lead sponsorPhase 2Oct 26, 2021
NCT05186753Study directorPhase 2Oct 26, 2021
NCT03680560Lead sponsorPhase 1Dec 31, 2018
NCT03680560Study directorPhase 1Dec 31, 2018
NCT03266692Study directorPhase 1Feb 22, 2018

Details

Founded: Cambridge, MA, US Jun 1, 2014
Last known activity: Jan 22, 2025